Table 1 Patient demographic, disease, and treatment-related characteristics for the entire study cohort (n = 79)
Characteristics | n (%) |
|---|---|
Male sex | 65 (82) |
Age at time of RT (years) | |
Median | 71 |
Range | 65–85 |
Time from end of RT to MDASI-HN completion (months) | |
Median | 46 |
Range | 6–117 |
Race | |
White | 75 (95) |
Black | 2 (3) |
Hispanic | 2 (3) |
Patient smoking status | |
Former | 40 (51) |
Current | 11 (14) |
Never | 28 (35) |
Tumor subsite | |
Base of tongue | 45 (57) |
Tonsil | 32 (41) |
Soft palate | 1 (1) |
Pharyngeal wall | 1 (1) |
T-category | |
T1 | 22 (28) |
T2 | 25 (32) |
T3 | 21 (27) |
T4 | 11 (14) |
N-category | |
N0 | 12 (15) |
N1 | 14 (18) |
N2a | 9 (11) |
N2b | 31 (39) |
N2c | 12 (15) |
N3 | 1 (1) |
Age-adjusted Charlson comorbidity index | |
Mean ± standard deviation | 2.62 ± 0.61 |
Treatment sequence | |
RT alone | 31 (39) |
CCRT | 27 (34) |
IC → CCRT | 14 (18) |
IC → RT | 7 (9) |
RT dose (Gray) | |
Mean ± standard deviation | 68.4 ± 2.12 |